Close Menu

Just Small Change

Merck is "actively looking" for biotechs to partner with or even purchase, CEO Dick Clark tells the Wall Street Journal Health Blog. Merck just completed its merger with Schering-Plough so Clark says such a large deal is "off the table right now" as the company settles in but "single-digit billions" of dollars deals could work.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.